The Schistosoma mansoni Sm14 antigen belongs to the fatty acid-binding protein (FABP) family and is considered a vaccine candidate against at least two parasite worms, F. hepatica and S. mansoni. Here, the genomic sequence and the polymorphism of Sm14 has been characterized for the first time. We found that the conserved methionine at position 20 is polymorphic, being exchangeable with threonine (M20T). To evaluate the function of the amino acid residue at this position, we have also constructed the mutant Sm14-A20 besides the two native isoforms (Sm14-M20 and Sm14-T20). The three purified recombinant 6xHis-tagged Sm14 proteins (rSm14-M20, rSm14-T20 and rSm14-A20) present a predominant β-barrel structure as by circular dichroism (CD) spectroscopy. Thermal and urea unfolding studies evidenced a higher structural stability of rSm14-M20 over the other forms (rSm14-M20>rSm14-T20>rSm14-A20). All Sm14 proteins were able to bind 11-(dansylamino) undecanoic acid (DAUDA), without substantial difference in the binding affinity. However, rSm14-M20 exhibited a higher affinity for natural fatty acids than the rSm14-T20 and rSm14-A20 proteins as judged by competitive experiments against DAUDA (rSm14-M20>rSm14-T20>rSm14-A20). The rSm14-M20 or rSm14-T20 isoforms, but not the rSm14-A20 mutant, were able to induce significant protection against S. mansoni cercariae challenge in immunized mice. The level of protection efficacy correlates with the extent of structure stability of the recombinant Sm14 isoforms and mutant. These results, besides suggesting that the M20T polymorphism may have potential functional consequences in the S. mansoni physiology, they also indicate that the Sm14-M20 isoform is a more suitable antigen for the development of a schistosomiasis vaccine. 
Introduction
Schistosomiasis is the second major parasitic disease in the World after malaria and afflicts over 200 million people. This disease is caused by blood flukes belonging to the genus Schistosoma (S. mansoni, S. japonicum or S. haematobium). In America, only S. mansoni is found, introduced from Africa in the colonial time (1) . These parasites lack the oxygen dependent pathways required for the synthesis of sterols and fatty acids, thus being entirely dependent on their hosts for these and other complex lipids supply. In fact, the intracellular fatty acid-binding protein Sm14 is particularly important for schistosomes in the uptake, transport and compartmentalization of host derived fatty acids (2) . Since these proteins play a vital role in their physiology and survival, they can represent an ideal target for vaccine development. Indeed, this parasite antigen is considered a promising vaccine candidate for human schistosomiasis by the World Health Organization (3). The S. mansoni Sm14 showed already a protective activity against two parasite worms, Fasciola hepatica and S. mansoni (4) . Recently, the T helper cells 1 (Th1) mediated immune response elicited by Sm14, has been associated with the resistance to schistosomiasis in individuals from endemic regions of Brazil (5) . For this reason, the study of the S. mansoni gene structure and polymorphism of Sm14 is of pivotal importance in order to identify the isoform better suited to devise an efficient vaccine. The data presented in this work indicate that the sequence of the various Sm14 proteins is relatively conserved among the American strains of S. mansoni and provide the first experimental evidence for the existence of a reduced polymorphism, especially with respect to S. japonicum FABPs. In particular, the single mutation M20T is the principal example in terms of recurrence. Interestingly, this change induces important structural and functional modifications in the protein that can have direct consequence in the development of a schistosomiasis vaccine based on this FABP. In fact, the more structurally stable Sm14-M20 isoform appears to be the better vaccine candidate.
(Life Technologies, Rockville, MD, USA), cloned into pGEM-T vector (Promega, Madison, WI, USA), and sequenced using the T7 and SP6 promoter primers. The nucleotide sequence analysis of Sm14 cDNAs were performed on the ABI PRISM 377 sequencer using the ABI PRISM Big Dye Terminator Cycle Sequencing kit.
PCR in vitro mutagenesis -To create site-directed mutation in the cDNA encoding for Sm14, we used the PCR in vitro mutagenesis method (7) . The amino acid residue at position 20, in this case methionine, was changed to alanine (M20→A20) using the forward F Expression and purification of the recombinant Sm14 proteins -The cDNA clones of the two native Sm14 isoforms (Sm14-M20 and Sm14-T20) and the mutant variant (Sm14-A20) cDNA clones were isolated from agarose gels after digestion with XhoI and MluI and ligated to the pAE expression vector (8) previously digested with the same enzymes. This vector allows the expression of recombinant proteins with a minimal N-terminal 6xHis-tag. The obtained constructs were used to transform E. coli BL21 (DE3) strain (Novagen, Madison, WI, USA). One
Liter of 2xYT medium (1.5% casein hydrolisate, 1% yeast extract, 0.5% NaCl; all w/v) was inoculated with 40ml of the overnight recombinant bacteria culture from single colonies and grown until the OD at 600 nm reached 0.6. The expression of the recombinant protein was induced with 1mM isopropyl-β-D-thiogalactoside (IPTG) and cultivated for additional 3 hours at 37 o C. The inclusion bodies containing the recombinant 6xHis-tagged protein were isolated from bacterial lysates and solubilized with 10 ml of buffer containing 8M urea, 0.05M Tris-HCl pH 8.0 and 0.005M 2-mercaptoethanol. The material was diluted 200x in the refolding buffer (0.005M imidazole, 0.5M NaCl, 0.05M Tris-HCl pH 8,0 and 0.005M 2-mercaptoethanol) and stirred for 16 hours at room temperature. After the refolding procedure, the recombinant protein was purified by metal-affinity chromatography in Chelating Sepharose Fast Flow resin (5 ml resin bed, 1 cm diameter column, Pharmacia, Uppsala, Sweden). Subsequently, the column was washed with refolding buffer and then the elution was carried out with a buffer containing 0.5M NaCl, 0.5M imidazole, 0.05M Tris-HCl, pH 6.8. The eluted protein was dialyzed against PBS.
For the CD experiments, the protein was dialyzed against 10mM Na-phosphate buffer, pH 7.4.
The protein purity was monitored by SDS-PAGE followed by Coomassie Brilliant Blue staining.
The concentrations of the soluble recombinant proteins were estimated from absorbance at 280 nm, considering an extinction molar coefficient of ε 280 =12325 M -1 cm -1 , based on the expected amino acid sequence of the recombinant protein.
Spectroscopic and protein stability studies -Equilibrium unfolding as a function of temperature was monitored by CD while the equilibrium unfolding as a function of denaturant concentration was studied by fluorescence spectroscopy. CD measurements were carried out on a Jasco J-810 Spectropolarimeter at 20 0 C equipped with a Peltier unit for temperature control. Far-UV CD spectra were acquired using a 1mm path length cell at 0.5 nm intervals over the wavelength range from 190 to 260 nm. Five scans were averaged for each sample and subtracted from the blank average spectra. The protein concentration was kept at 10µM in 10mM Naphosphate buffer as described above. The temperature range was from 15 to 75 0 C. The loss of Vaccination experiments -The three recombinant proteins, rSm14-M20, rSm14-T20 and rSm14-A20, were evaluated for vaccine efficacy in 4 -6 week old female outbred Swiss mice as previously described (4, 9) . Briefly, mice received three subcutaneous inoculations with 7 day intervals of recombinant proteins in PBS emulsified in aluminum hydroxide as adjuvant. Control mice were injected with PBS plus adjuvant. The animals were further challenged percutaneously with 100 cercariae (LE strain)/mouse 60 days after the last immunization dose and perfused 45 days later. The overall protection efficiency was calculated by the equation
where C is the average number of worms in control animals and V is the average number of worms in vaccinated animals. Statistical analysis was done with Student's t test (P<0.05).
Results and Discussion
Sm14 genomic sequence and organization -The genomic sequence of Sm14 was amplified by PCR using DNA isolated from a pool of adult worms of the Brazilian endemic S.
mansoni BH strain. The amplified product is larger than that amplified from RNA, indicating the presence of introns (data not shown). The amplified 1.7 kbp genomic DNA segment was cloned and sequenced from two independent PCR clones (GenBank accession AY055467). The sequence analysis revealed the sites of exon-intron junctions. All intron-exon boundaries obey the GT/AG rule (10) ( Figure 1A ). The exon nucleotide sequences were identical to that previously reported for Sm14 cDNA cloned from the Puerto Rican strain of S. mansoni (11).
Like the other members of the FABP gene family, the gene for Sm14 contains four exons separated by three introns (12). Recently, the presence and position of the introns in the related FABP gene from S. japonicum was also determined by PCR and corresponded exactly to that observed here for S. mansoni ( Figure 1B ) (13). The comparison of helminth and mammalian
FABPs genes showed that the sizes and positions of FABP exons are conserved among these organisms, whereas the size of the introns is quite variable (12) ( Table I) japonicum, we speculated that in S. japonicum, the presence of a second 3´-acceptor site for the intron 1 at the beginning of the exon 2 would explain the generation of S. japonicum F25
transcript. This same alternative splicing could also be used to generate an orthologous S.
mansoni F25 variant (shown by an arrow in the Figure 1A ). After alternative splicing of intron 1 using this putative splice site, the first 12 amino acids of exon 2 could be excised while all the remaining codons would remain in frame, exactly as observed in S. japonicum F25. This second splice site for intron 1, however, lacks the characteristic pyrimidine rich sequence in the intronexon junction (10), and therefore, as previously postulated for S. japonicum F25 (13), we do not expect this event to occur frequently.
When the obtained Sm14 genomic sequence was aligned with the nucleic acid sequences of other members of the FABP gene family, the positioning of each of the three introns was found to be conserved. As shown in Figure 2 , the first intron always divides a codon after its first nucleotide, in contrast to the other exon/intron borders, which are located after the entire codon (14) . It is worth to note, however, that, in spite of this highly conserved gene organization, as well as of their affinity for fatty acids (17) . Based on these evidences and since the nature of the threonine is very different from the methionine in terms of hydrophobicity and chain size, we expect to observe significant differences between the two main isoforms of Sm14.
Structural analysis of Sm14 -The recombinant 6xHis-tagged Sm14 proteins (rSm14-M20
and rSm14-T20) were expressed and purified using a metal affinity chromatography. An additional mutant form (rSm14-A20) was also constructed in order to better evaluate the importance of this amino acid residue in the Sm14 protein. Single protein bands with molecular masses about 16 kDa were observed for rSm14-M20 and rSm14-T20 when subjected to SDS-PAGE analysis as well as for rSm14-A20 protein (data not shown). Figure 5A (black line) shows that the three rSm14 proteins present a CD spectrum typical of a protein possessing a secondary structure containing mainly β-structural elements in agreement with the prediction based on its primary sequence (4). Overall, the CD spectra evidence some differences in the chiroptical activity of the three proteins suggesting that indeed a single mutation at position 20 influences their structural features. The stability of the protein was assessed both by CD and fluorescence spectroscopy. Figure 5B shows the trace of thermal unfolding of the three rSm14 proteins. The sigmoidal shape indicates we are in the presence of a two state transition though, as also indicated by the CD spectra obtained after cooling down the protein, the transition is not completely reversible ( Figure 5A , light grey line). The secondary structure recovery was higher for the rSm14-M20, followed by rSm14-T20 and rSm14-A20 (82.6%, 64.4% and 56.8%, respectively). The CD spectra at high temperature ( Figure 5A , dark grey line) recorded when the ellipticity at 216 nm has reached a plateau, though they indicate a protein mainly unfolded, still present a negative shoulder at 222 nm, suggesting the presence of some residual helical determinants ( Figure 5A ). It is interesting to note that despite the fact that distinct fatty acid binding proteins have similar β-barrel structure, they may have different folding and unfolding intermediates (20) . From the fitting of the CD traces recorded at increasing temperature ( Figure 5B ), the temperature of unfolding of each protein variant has been derived, showing that the rSm14-M20 isoform was more stable (Tm = 55.3 0 C) than rSm14-T20 isoform and rSm14-A20 mutant (Tm = 44.6 and 45.8, respectively). The folding stability of the three rSm14 variants has also been investigated by following the change of their fluorescence emission maximum as a function of increasing concentration of urea. The data confirmed that indeed rSm14-M20 has a higher structural stability (results not shown). The data show that the rSm14-M20 has the higher affinity for all the natural fatty acids. Overall, the results indicate that the efficiency in the displacement of DAUDA increases with the increase of both the fatty acid length and the number of insaturations (12) and, as observed for other FABPs, confirm the importance of the nature of the amino acid residue at position 20 in Sm14. It is interesting to observe that in the case of rSm14-A20, the myristic acid is not able to displace DAUDA evidencing, differently from the other rSm14 proteins, an absence of affinity of the mutant for this relatively short fatty acid. A possible key to interpret the similarities and differences in affinity, exhibited by the three Sm14 proteins with respect to DAUDA and to the various fatty acids, can be derived by the analysis of the crystallographic structure of human B-FABP that reveals that only long chain fatty acids are able to interact with Met20 (25) . Based on this observation, we can hypothesize that due to its short chain, DAUDA (only 11 carbon atoms)
will not be able to interact with any residue might be present in position 20, thus justifying the equivalent affinity exhibited by the three proteins for the fluorescent fatty acid probe ( Figure 6 ).
On the other hand, the competition experiments (Figure 8 ), where longer fatty acids have been used, revealed the existence of distinct affinities that very likely are due to selective contacts between the fatty acid and the distinct residue at position 20 of the rSm14 proteins.
Altogether, these results indicate that the nature of the amino acid at position 20 is very important for structure stability and for the binding features to fatty acids.
Vaccination experiments -The protection efficacy of the three rSm14 proteins against S.
mansoni cercariae was evaluated in outbred Swiss mice as previously described (4) . As shown in Figure 9 , rSm14-T20 or rSm14-M20 proteins stimulated a significant protective response (44 and 67%, respectively). Animals vaccinated with these proteins showed a reduction in mean worm burden with values close to or higher than the 40% reduction value defined by WHO as a prerequisite for an antigen to be considered a potential vaccine candidate against human schistosomiasis. Exception is the rSm14-A20 mutant that turned out to be a poor protective and 25) and therefore, is not expected to be exposed as an epitope. Nonetheless, the data described here demonstrate the importance of this residue in modulating some structural and functional features of Sm14. Thus, the lack of significant protective ability for rSm14-A20 is probably the result of these properties rather than the change of the epitope exposure. The rSm14-A20 was the more unstable and less structured Sm14 protein (data not shown, Figure 5 ).
The rSm14-M20 showed the highest secondary structure recovery (82.5%) after heating to 80 0 C, followed by rSm14-T20 (64.3%) ( Figure 5A ) and was more resistant to denaturation by urea as followed by intrinsic fluorescence of tryptophane (results not shown). These properties correlate well with the level of protective ability observed ( Figure 9 ). In fact, heating the rSm14-T20 just before the immunization of the animals resulted in a poor protective response, similar to that observed for rSm14-A20 mutant, thus suggesting that for immune protection, Sm14 has to possess the correct fold. This is an important observation for the development of a Sm14 based vaccine (3) and it implies that a quality control that take into account the structure integrity of the protein has to be included in the production of rSm14.
In conclusion, the data presented here show for the first time the genomic organization of the Sm14 protein and the existence of polymorphism. A preliminary evaluation of the structural and functional features of the some of these mutants has revealed that the Sm14-M20 isoform, characterized by a higher structural stability and by a more pronounced affinity for natural fatty acids, appears to be the more suitable antigen for the development of the schistosomiasis vaccine.
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